How to buy InVivo Therapeutics stock (NVIV)

InVivo Therapeutics is a biotechnology business based in the US. InVivo Therapeutics shares (NVIV) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.32 – the same closing value as a week prior. InVivo Therapeutics employs 6 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy InVivo Therapeutics stock

Buy InVivo Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

InVivo Therapeutics stock price (NASDAQ: NVIV)

Use our graph to track the performance of NVIV stocks over time.

InVivo Therapeutics shares at a glance

• Key figures

Information last updated 2024-04-07.

Latest market close	$0.32
52-week range	$0.22 - $1.05
50-day moving average more info button	$0.61
200-day moving average more info button	$0.99
Wall St. target price	$37.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-3.28

Is it a good time to buy InVivo Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

InVivo Therapeutics price performance over time

Historical closes compared with the close of $0.3207 from 2024-02-12

1 week (2024-10-18)	N/A
1 month (2024-09-25)	N/A
3 months (2024-07-25)	N/A
6 months (2024-04-25)	N/A

1 year (2023-10-27)	-65.52%
2 years (2022-10-28)	-86.24%
3 years (2021-10-29)	0.58
5 years (2019-10-29)	14.4

InVivo Therapeutics financials

Gross profit TTM	$0
Return on assets TTM	-53.71%
Return on equity TTM	-98.11%
Profit margin	0%
Book value	$2.87
Market Capitalization more info button	$995,917

TTM: trailing 12 months

InVivo Therapeutics share dividends

We're not expecting InVivo Therapeutics to pay a dividend over the next 12 months.

Have InVivo Therapeutics's shares ever split?

InVivo Therapeutics's shares were split on a 1:25 basis on 26 April 2022 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InVivo Therapeutics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for InVivo Therapeutics shares which in turn could have impacted InVivo Therapeutics's share price.

InVivo Therapeutics share price volatility

Over the last 12 months, InVivo Therapeutics's shares have ranged in value from as little as $0.222 up to $1.05. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InVivo Therapeutics's is 0.658. This would suggest that InVivo Therapeutics's shares are less volatile than average (for this exchange).

InVivo Therapeutics overview

InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). It is developing a Neuro-Spinal Scaffold implant comprise of biocompatible and bioresorbable polymers, which includes Poly lactic-co-glycolic acid, a polymer which is widely used in resorbable sutures and provides the biocompatible support for Neuro-Spinal Scaffold implant; and Poly-L-Lysine, a positively charged polymer used to coat surfaces to promote cellular attachment. The company was incorporated in 2003 and is headquartered in Cambridge, Massachusetts. On February 1, 2024, InVivo Therapeutics Holdings Corp. filed a voluntary petition for reorganization under Chapter 11 in the U.

Frequently asked questions

What percentage of InVivo Therapeutics is owned by insiders or institutions?
Currently 0.021% of InVivo Therapeutics shares are held by insiders and 3.444% by institutions. How many people work for InVivo Therapeutics?
Latest data suggests 6 work at InVivo Therapeutics. When does the fiscal year end for InVivo Therapeutics?
InVivo Therapeutics's fiscal year ends in December. Where is InVivo Therapeutics based?
InVivo Therapeutics's address is: One Kendall Square, Cambridge, MA, United States, 02139 What is InVivo Therapeutics's ISIN number?
InVivo Therapeutics's international securities identification number is: US46186M6057 What is InVivo Therapeutics's CUSIP number?
InVivo Therapeutics's Committee on Uniform Securities Identification Procedures number is: 46186M506